Skip to main content
Log in

Hematopoietic Stem Cell Transplantation Successfully Treats CD40LG Duplication

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Blair PJ, Riley JL, Harlan DM, Abe R, Tadaki DK, Hoffmann SC, et al. Cd40 ligand (Cd154) triggers a short-term Cd4+ T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J Exp Med. 2000;191:651–60.

    Article  CAS  Google Scholar 

  2. Higuchi T, Aiba Y, Nomura T, Matsuda J, Mochida K, Suzuki M, et al. Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol. 2002;168:9–12.

    Article  CAS  Google Scholar 

  3. Karnell JL, Rieder SA, Ettinger R, Kolbeck R. Targeting the CD40-CD40L pathway in autoimmune diseases: humoral immunity and beyond. Adv Drug Deliv Rev. 2019;141:92–103.

    Article  CAS  Google Scholar 

  4. Le Coz C, Trofa M, Syrett CM, Martin A, Jyonouchi H, Jyonouchi S, et al. CD40LG duplication-associated autoimmune disease is silenced by nonrandom X-chromosome inactivation. J Allergy Clin Immunol. 2018;141:2308-2311.e7.

    Article  Google Scholar 

  5. Dunn RJ, Luedecker CJ, Haugen HS, Clegg CH, Farr AG. Thymic overexpression of CD40 ligand disrupts normal thymic epithelial organization. J Histochem Cytochem. 1997;45:129–41.

    Article  CAS  Google Scholar 

Download references

Funding

N.R. receives salary support from the Jeffrey Modell Foundation. D.S. is funded by NICHD-T32HD043021.

Author information

Authors and Affiliations

Authors

Contributions

C.LC. and N.R. planned the experiments. D.S. and C.LC. performed the experiments and completed data analysis. D.S. and N.R. wrote the manuscript, and C.LC. and N.B. edited the manuscript. N.B. and N.R. provided patient clinical data. All authors approve of the manuscript.

Corresponding author

Correspondence to Neil Romberg.

Ethics declarations

Consent for Publication

All authors have reviewed the manuscript and consented to publication.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

10875_2021_1085_MOESM1_ESM.pdf

Supplemental Figure 1: (upper panel) Lymphocyte, myeloid cell and (lower panel) T-cell receptor excision circle (TREC) concentrations are displayed relative to the day zero donor stem cell infusion (dashed vertical line). (PDF 440 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, D., Le Coz, C., Bunin, N. et al. Hematopoietic Stem Cell Transplantation Successfully Treats CD40LG Duplication. J Clin Immunol 41, 1668–1670 (2021). https://doi.org/10.1007/s10875-021-01085-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-021-01085-5

Navigation